# Ultrasound assessment of tibial nerve cross-sectional area in diabetic peripheral neuropathy in the Thai Population

**Authors:** Athikhun Suwannakhan, Sittichai Khamsai, Thongchai Pratipanawatr, Woranan Kirisattayakul, Waranon Munkong, Nongnuch Prab Na Sak, Waritsara Phonsena, Sitthichai Iamsaard, Thanyaporn Senarai

PMC · DOI: 10.1371/journal.pone.0343128 · PLOS One · 2026-02-25

## TL;DR

This study explores using ultrasound to measure tibial nerve thickness in Thai diabetic patients to detect peripheral neuropathy early.

## Contribution

The study evaluates tibial nerve cross-sectional area as a potential diagnostic marker for diabetic peripheral neuropathy in a Thai population.

## Key findings

- Tibial nerve cross-sectional area was significantly larger in patients with diabetic peripheral neuropathy.
- A threshold of 13 mm² showed moderate sensitivity and specificity for detecting neuropathy.
- CSA correlated with clinical neuropathy scores and was an independent predictor of neuropathy status.

## Abstract

Early recognition of DPN gives physicians the opportunity to deliver appropriate treatment and counseling to minimize subsequent complications. This study aimed to evaluate the diagnostic performance of tibial nerve cross-sectional area (CSA) in detecting DPN using a Modified Toronto Clinical Neuropathy Score (mTCNS) ≥ 3 as the diagnostic reference in Thai diabetic patients. A total of 67 diabetic patients (120 limbs) were enrolled from Srinagarind Hospital between 2022 and 2023. A total of 120 limbs belonging to 67 patients were categorized into two groups: non-DPN group (mTCNS < 3) (n = 42) and DPN group (mTCNS ≥ 3) (n = 78). Tibial nerve CSA was measured 3 cm proximal to the medial malleolus using ultrasound. Clinical parameters and metabolic profiles were recorded. Receiver operating characteristic analysis, correlation analyses, and multivariable logistic regression were performed to evaluate diagnostic utility and associations between CSA and clinical parameters. The tibial nerve CSA was significantly higher in the DPN group (13.49 mm2, 95% CI: 12.84–14.13) compared to the non-DPN group (11.98 mm2, 95% CI: 10.95–13.02) (p = 0.015). A CSA threshold of 13 mm2 yielded a sensitivity of 58.5% and specificity of 74.2%. CSA positively correlated with mTCNS (r = 0.49, p < 0.001) and sensation score (r = 0.37, p = 0.002) in DPN patients. Logistic regression identified CSA and estimated glomerular filtration rate as independent predictors of DPN status. Tibial nerve CSA may serve as a useful structural marker to support the identification of DPN. When used alongside established clinical assessments, CSA measurement could contribute to earlier detection and improved risk stratification in diabetic populations.

## Full-text entities

- **Diseases:** nerve abnormalities (MESH:D005155), amputation (MESH:C565682), death (MESH:D003643), ataxia (MESH:D001259), nerve damage (MESH:D000080902), mTCNS (MESH:D029242), cardiovascular and cerebrovascular diseases (MESH:D002318), vitamin deficiencies (MESH:D014802), numbness (MESH:D006987), mononeuropathies (MESH:D020422), ulcers (MESH:D014456), type 2 diabetes mellitus (MESH:D003924), tingling (MESH:D010292), DPN (MESH:D010523), nerve enlargement (MESH:D006332), sensory loss (MESH:C580162), type 1 diabetes (MESH:D003922), neuromuscular disorders (MESH:D009468), foot ulcer (MESH:D016523), Neuropathy (MESH:D009422), cognitive decline (MESH:D003072), CSA (MESH:C537866), complications (MESH:D008107), wounds (MESH:D014947), pain (MESH:D010146), DM (MESH:D003920), impaired sensory function (MESH:D012678), weakness (MESH:D018908), polyneuropathy (MESH:D011115), chronic kidney disease (MESH:D051436), retinopathy (MESH:D058437), metabolic dysfunction (MESH:D008659)
- **Chemicals:** CSA (-), DPN (MESH:D009243), sugar (MESH:D000073893), triglyceride (MESH:D014280), blood sugar (MESH:D001786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935226/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935226/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935226/full.md

---
Source: https://tomesphere.com/paper/PMC12935226